Brief: Pharmaust Seeks Trading Halt
10/07/2023 02:35
July 10 (Reuters) - Pharmaust Ltd PAA.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON URINARY
BIOMARKER
RESULTS FROM MOTOR NEURONE DISEASE PHASE 1/2 CLINICAL TRIAL
Source text for Eikon: ID:nASX7SvW0s
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO